Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-09-18Clinical Trial Update: Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy [Phase 2]
Phase II study evaluating curcumin versus placebo in chemotherapy-treated breast cancer patients undergoing radiotherapy has completed with …
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer [Phase 2]
Phase II trial evaluating markers to predict response to a combined therapy in HER2-positive breast cancer, terminated with results posted i…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer [Phase 3]
Phase 3 trial comparing vinflunine to an alkylating agent in metastatic breast cancer completed; results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Vitamin D Supplementation to Correct the Vitamin D Deficiency for Breast Cancer [Phase 2]
Phase 2 trial evaluating vitamin D supplementation to correct vitamin D deficiency in breast cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Recombinant Human Serum Albumin/Granulocyte Colony Stimulating Factor Fusion Protein for Breast Cancer Patients [Phase 2]
Phase 2 trial update for a recombinant human serum albumin/G-CSF fusion protein in breast cancer patients undergoing chemotherapy, completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-09-13Clinical Trial Update: Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer [Phase 3]
Phase 3 trial evaluating vinflunine plus capecitabine in advanced breast cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer [Phase 2]
Phase 2 trial comparing docetaxel alone versus docetaxel combined with gemcitabine in breast cancer has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Pyrotinib Combined With Trastuzumab Plus Aromatase Inhibitor in Treatment of Breast Cancer [Phase 2]
Phase 2 trial evaluating pyrotinib with trastuzumab and an aromatase inhibitor for HER2-positive breast cancer showing ongoing status with n…
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Trastuzumab and NK Immunotherapy for Recurrent Breast Cancer [Phase 1, Phase 2]
Combination of trastuzumab with NK immunotherapy studied in recurrent breast cancer across Phase 1 and Phase 2; trial completed.
-
CLINICAL_TRIALS trial_result · 2019-09-12Clinical Trial Update: Combination of Cryosurgery and NK Immunotherapy for Advanced Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the combination of cryosurgery and NK cell immunotherapy for breast cancer (recurrent) has completed.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Phase 2 Etirinotecan Pegol in Refractory Brain Metastases & Advanced Lung Cancer / Metastatic Breast Cancer [Phase 2]
Phase 2 trial update for etirinotecan pegol in refractory brain metastases, extensive-stage small cell lung cancer, recurrent NSCLC, metasta…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Recurrence Score-guiding Chemotherapy in Non-pCR HR Positive HER2 Negative Breast Cancer After Neoadjuvant Therapy [Phase 2]
Phase 2 clinical trial evaluating recurrence score-guided chemotherapy in HR-positive, HER2-negative breast cancer after neoadjuvant therapy…
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer [Phase 2]
Phase II trial investigating neoadjuvant metronomic chemotherapy in triple-negative breast cancer was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-09-10Clinical Trial Update: Feasibility Study of Meso BioMatrix Device for Breast Reconstruction [NA]
Feasibility study update for the Meso BioMatrix device in breast reconstruction following breast cancer treatment; study completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients [Phase 1, Phase 2]
Clinical trial update on dasatinib combined with trastuzumab and paclitaxel in first-line HER2-positive metastatic breast cancer (Phase 1/2;…
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer
A completed clinical trial assessing echocardiographic changes during adjuvant therapy in Hispanic women with HER2-positive breast cancer.
-
CLINICAL_TRIALS trial_result · 2019-09-09Clinical Trial Update: Automated Breast Ultrasound Case Collection Registry
A clinical trial registry entry for an automated breast ultrasound case collection registry related to breast cancer has been terminated, wi…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer [Phase 3]
Phase IIIb trial evaluating safety and tolerability of Herceptin SC with Perjeta and docetaxel in HER2-positive advanced breast cancer has c…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Combining Doxycycline With Bone-Targeted Therapy in Patients With Metastatic Breast Cancer [Phase 2]
Phase 2 clinical trial update evaluating doxycycline in combination with bone-targeted therapy for patients with metastatic breast cancer, c…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: A Study to Compare Administration Schedules of G-CSF (Filgrastim) for Primary Prophylaxis of Febrile Neutropenia [Phase 4]
Phase 4 trial updating administration schedules of G-CSF (Filgrastim) for primary prophylaxis of febrile neutropenia in early stage breast c…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Optimizing Decision Making About Breast Reconstruction After Mastectomy: A Patient-Centered Approach [Phase 1]
Phase 1 trial update focusing on patient-centered decision making for breast reconstruction after mastectomy in breast cancer patients; resu…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Internet-based Cognitive Behavioral Therapy for Breast Cancer Patients With Climacteric Symptoms [Phase 3]
Phase 3 clinical trial evaluating internet-based cognitive behavioral therapy for climacteric symptoms in breast cancer survivors has comple…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer [Phase 3]
Phase 3 trial evaluating Doxorubicin, Cyclophosphamide, and Paclitaxel with or without Bevacizumab in patients with lymph node-positive or h…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer [Phase 4]
Phase 4 clinical trial update evaluating MK-0752 in combination with tamoxifen or letrozole for early-stage breast cancer has completed; res…
-
CLINICAL_TRIALS trial_result · 2019-09-04Clinical Trial Update: Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. [Phase 2]
Phase 2 Neoadjuvant trial evaluating a fixed-dose combination with melatonin or metformin for locally advanced breast cancer.